Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Corken Mackey

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of the American Pharmacists Association : Japha|January 11, 2005
Tardive dyskinesia risks and metoclopramide use before and after U.S. market withdrawal of cisaprideDouglas Shaffer, Marian Butterfield, Carol Pamer, et al.
The Oncologist|April 6, 2012
Accumulating evidence for a drug-drug interaction between methotrexate and proton pump inhibitorsShewit Bezabeh, Ann Corken Mackey, Paul Kluetz, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 27, 2007
Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel diseaseAnn Corken Mackey, Lanh Green, Li-Ching Liang, et al.
Pharmacoepidemiology and Drug Safety|March 20, 2003
Improving the quality of adverse drug reaction reporting by 4th-year medical studentsCurtis J Rosebraugh, Yi Tsong, Feng Zhou, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of the American Pharmacists Association : Japha|January 11, 2005
Tardive dyskinesia risks and metoclopramide use before and after U.S. market withdrawal of cisaprideDouglas Shaffer, Marian Butterfield, Carol Pamer, et al.
The Oncologist|April 6, 2012
Accumulating evidence for a drug-drug interaction between methotrexate and proton pump inhibitorsShewit Bezabeh, Ann Corken Mackey, Paul Kluetz, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 27, 2007
Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel diseaseAnn Corken Mackey, Lanh Green, Li-Ching Liang, et al.
Pharmacoepidemiology and Drug Safety|March 20, 2003
Improving the quality of adverse drug reaction reporting by 4th-year medical studentsCurtis J Rosebraugh, Yi Tsong, Feng Zhou, et al.
Pageof 1